Investment Rating - The investment rating for Alibaba-W (09988.HK) is "Outperform" [1][6][4] Core Views - The report anticipates a revenue growth of 2% year-on-year for 3QFY26, with an expected revenue of 285.8 billion yuan. The adjusted EBITA margin is projected to be 11.7%, reflecting a decline of 7.8 percentage points year-on-year [3][5] - The international digital commerce group and cloud intelligence revenue are expected to grow by 8% and 35% year-on-year, respectively, indicating continued acceleration in cloud revenue growth [3][10] - The report highlights the ongoing investment in AI and model training, which is expected to impact profitability in the short term but may enhance competitive positioning in the long run [11][22] Summary by Sections Financial Performance - For 3QFY26, Alibaba is projected to achieve a revenue of 285.8 billion yuan, with a year-on-year increase of 2%. The adjusted EBITA is expected to be 33.5 billion yuan, down 39% year-on-year [3][5] - The adjusted EBITA margin is forecasted at 11.7%, a decrease of 7.8 percentage points compared to the previous year [5][3] Cloud Business - The cloud segment is expected to see a revenue increase of 35% year-on-year in FY26Q3, with a stable EBITA margin. The Qwen model is anticipated to enhance the company's market share in overseas markets [10][11] E-commerce Performance - The e-commerce group's GMV is expected to grow by 3% year-on-year in FY26Q3, influenced by a weak retail environment. The report notes that the monetization rate is expected to align closely with GMV growth [19][21] - Instant retail is projected to incur losses of approximately 20-25 billion yuan, with a focus on maintaining market share through increased investment [21][22] Financial Forecasts - Revenue forecasts for FY2026-FY2028 have been slightly adjusted to 1,030.7 billion, 1,149.4 billion, and 1,275.1 billion yuan, reflecting a decrease of 1.5%, 2.8%, and 1.4%, respectively, due to a soft consumer environment [4][23] - Adjusted net profit forecasts for FY2026-FY2028 are revised to 101.6 billion, 135.4 billion, and 165.5 billion yuan, with adjustments of -9.1%, -6.6%, and -3.7% respectively [4][23]

Investment Rating - The report indicates a positive outlook for WuXi Biologics, suggesting that the company will outperform its peers in the biopharmaceutical CDMO sector in 2026 [5]. Core Insights - WuXi Biologics is expected to experience a reacceleration in growth in 2026, driven by three main catalysts: the growth momentum from dual/multi-antibody projects, a strong project intake in 2025 with a net addition of 128 projects, and a reduction in valuation pressure from geopolitical factors [5][8]. - The non-XDC business of WuXi Biologics is anticipated to accelerate in 2026, contrary to market expectations, returning the company to a multi-engine growth trajectory [6]. - The company’s dual/multi-antibody projects are projected to be a significant growth driver, with a 30% year-on-year increase in project numbers for 2025, outpacing the overall company growth rate of 16% [7]. Summary by Sections Company Overview - WuXi Biologics is a leading global contract research, development, and manufacturing organization (CRDMO) that provides end-to-end solutions to help partners develop biopharmaceuticals from concept to commercialization [10]. Financial Performance - As of January 9, 2026, the stock price is HKD 37.06, with a market capitalization of USD 19.65 billion. The average daily trading volume over the past three months is USD 138.43 million [13]. - The revenue breakdown shows that biopharmaceuticals account for 88.8% of total revenue, while WuXi XDC contributes 11.2% [11]. Growth Drivers - The report highlights that the strong project intake in 2025, with 128 new projects, sets a solid foundation for faster growth in 2026 compared to 2025 [5][8]. - The profitability outlook is favorable due to the optimization of the project structure towards complex dual/multi-antibody projects, which is expected to enhance profit margins [7].

Investment Rating - The report assigns a "Buy" rating to the company, indicating a positive outlook for the stock price over the next six months [6]. Core Insights - The report highlights that Weimeng Group is a leading AI+SaaS service provider in China, with its product "Xingqi GEO" successfully commercialized. The company achieved total revenue of 775 million yuan in the first half of 2025, reflecting a year-on-year decline of 10.6%, but an adjusted revenue increase of 7.8% [1][4]. - AI-related revenue reached 34 million yuan in the first half of 2025, indicating a breakthrough in AI product offerings. The report anticipates that the GEO product will contribute significantly to performance by 2026 [1][4]. - The global GEO market is projected to grow significantly, with an estimated size of approximately 11.2 billion USD by 2025 and 100.7 billion USD by 2030. In China, the GEO market is expected to reach about 2.9 billion yuan by 2025 and 24 billion yuan by 2030 [2]. - The report emphasizes that Weimeng's GEO services have benefited clients across various industries, with significant improvements in AI visibility and advertising effectiveness [3]. Financial Summary - The financial projections for Weimeng Group indicate expected revenues of 1.57 billion yuan in 2025, 1.76 billion yuan in 2026, and 1.89 billion yuan in 2027, with corresponding net profits of -156 million yuan, -18 million yuan, and 74 million yuan respectively [5][10]. - The report notes a projected increase in customer numbers, customer stickiness, and ARPU (Average Revenue Per User) due to the successful implementation of AI products and GEO upgrades [4].

Investment Rating - The report assigns an "Outperform" rating to the company [6]. Core Insights - The company, Laopu Gold, is experiencing accelerated growth in its high-end gold jewelry retail business, with a projected revenue of 12.354 billion yuan for the first half of 2025, representing a year-on-year increase of 251%, and a net profit of 2.268 billion yuan, up 286% [2][4]. - The brand's positioning as a high-end product with a focus on traditional craftsmanship is driving its growth, supported by a fully direct sales model and a significant increase in both offline and online sales channels [2][3]. - The demand for gold jewelry is expected to continue growing due to the rising fashion attributes of gold products and the increasing purchasing power of younger consumers [3][57]. Financial Performance - The company is projected to achieve a net profit of 4.84 billion yuan in 2025, with corresponding PE ratios of 22.4, 16.6, and 13.4 for the years 2025, 2026, and 2027 respectively [4][5]. - Revenue is expected to grow significantly, with estimates of 28.05 billion yuan in 2025, 37.25 billion yuan in 2026, and 45.20 billion yuan in 2027, reflecting a compound annual growth rate of 156% from 2022 to 2024 [5][19]. Market Positioning - Laopu Gold operates 41 stores across 16 cities, with a strong presence in high-end shopping centers, and has achieved a significant increase in average store revenue, which reached 207 million yuan in 2024, up 120.28% year-on-year [2][19]. - The company has successfully integrated product design, processing, and retail into a cohesive management system, allowing it to maintain a competitive edge in a market characterized by product homogeneity [3][67]. Consumer Trends - The report highlights a shift in consumer preferences towards gold jewelry that combines fashion and value retention, particularly among younger demographics, who are increasingly contributing to gold jewelry sales [3][55]. - The high-end consumer market remains resilient, with luxury brands showing strong performance, which bodes well for Laopu Gold's positioning in the market [57][64].

Investment Rating - The report maintains a "Buy" rating for the company 361 Degrees [6] Core Insights - The company reported strong growth in Q4 2025, with adult apparel and children's apparel offline channel revenue both increasing by approximately 10%. E-commerce revenue recorded high double-digit growth, aligning with expectations [1] - The company is expected to achieve a revenue growth of 11.4% in 2025 and a net profit growth of 9.5%. The growth trend is anticipated to continue into 2026 [4] - The company has launched several flagship technology products across various sports categories, enhancing its market presence and meeting diverse consumer needs [2] Product Summary - In the running category, the company introduced the "Flying Burn 5" and "Flying Burn 5 FUTURE" shoes, along with upgraded models "Speed Float 3" and "Speed CQT 3". The basketball segment saw the launch of the second signature shoe for Jokic, "JOKER2", and Gordon's sixth signature shoe, "AG6" [2] - The company is also focusing on outdoor, women's fitness, and cross-training segments to cater to a wider audience [2] Brand Summary - The company has strengthened its brand influence by partnering with the Olympic Council of Asia and becoming the official supplier for the 2025 WTCC World Tennis Continental Championship [2] - The brand's ambassador, Li Zicheng, won championships at the Fuzhou and Tangshan marathons, showcasing the competitive edge of its professional racing gear [2] Channel Summary - The company has rapidly expanded its super stores, reaching a total of 126 in mainland China by December 31, 2025, contributing significantly to its growth [3] - The first overseas super store opened in Cambodia, marking a substantial step in the company's international retail strategy [3] - E-commerce revenue showed high double-digit growth, with a thousand stores joining Taobao Flash Sale, enhancing the integration of online and offline sales [3] Financial Projections - The company is projected to achieve a net profit of 1.258 billion yuan in 2025, with estimates of 1.397 billion yuan in 2026 and 1.571 billion yuan in 2027 [4] - The price-to-earnings (P/E) ratio for 2026 is expected to be 8 times, indicating a favorable valuation [4]

Investment Rating - The report maintains a "Buy" rating for the company 361 Degrees [5] Core Insights - The company demonstrated strong growth resilience with a year-on-year increase of approximately 10% in offline retail sales for both the main brand and children's clothing in Q4 2025, maintaining the same growth rate as Q3 2025 [2] - E-commerce sales continued to outperform offline channels, with high double-digit year-on-year growth in Q4 [2] - The company is focused on brand building and has announced a new strategic partnership with the Olympic Council of Asia, showcasing its commitment to innovation and sustainability through product launches [3] - The company has accelerated its layout in instant retail, with over 1,000 stores joining Taobao Flash Purchase, and has opened its first overseas store in Cambodia [3] - Revenue projections for 2025-2027 indicate a growth of 13.8%, 11.1%, and 10.1%, reaching 11.47 billion, 12.74 billion, and 14.03 billion yuan respectively, with net profit expected to grow by 11.6%, 15%, and 10.3% [3] Financial Summary - For 2023, the company reported a revenue of 8,423.26 million yuan, with a year-on-year growth of 21.01%. Projections for 2024 and 2025 are 10,073.51 million yuan and 11,466.19 million yuan respectively, with growth rates of 19.59% and 13.83% [4] - The net profit attributable to the parent company for 2023 was 961.43 million yuan, with expected growth to 1,148.62 million yuan in 2024 and 1,281.74 million yuan in 2025, reflecting growth rates of 28.68% and 11.59% [4] - The earnings per share (EPS) is projected to increase from 0.47 yuan in 2023 to 0.56 yuan in 2024 and 0.62 yuan in 2025 [4]

Investment Rating - The report assigns a "Buy" rating for the company, with a target price of 114.6 RMB / 128.3 HKD, indicating approximately 50% upside potential from the current stock price of 86.8 HKD [1]. Core Insights - The company is a leader in the siRNA field, focusing on chronic diseases and has developed proprietary delivery technologies with global competitiveness. It has established strategic partnerships, including one with Boehringer Ingelheim, which could yield up to 2.36 billion euros in milestone payments [7][19]. - The global market for small nucleic acid drugs is projected to grow significantly, from 5.7 billion USD in 2024 to 54.9 billion USD by 2033, with a CAGR of 21%-29% [7][43]. - The company's FXI siRNA product has the potential to tap into a market space worth over 10 billion USD, addressing significant clinical needs in the anticoagulant drug market [7][43]. Summary by Sections Company Overview - The company, established in 2007, specializes in siRNA drug development and has built a comprehensive industry chain from drug discovery to commercialization, becoming a global leader in the small nucleic acid drug development field [13][14]. Market Potential - The small nucleic acid drug market is expected to grow rapidly, with siRNA drugs projected to capture a larger market share due to advancements in delivery systems and chemical modifications [43][45]. - The report highlights that the siRNA market is anticipated to grow at a higher rate than ASO drugs, with siRNA drugs expected to account for 44.5% of the market by 2024 [43][45]. Product Pipeline - The company has a robust pipeline with four candidates in Phase 2 clinical trials and over 20 projects in preclinical stages, demonstrating a strong capability to advance multiple assets to clinical development each year [26][24]. - Key products include FXI siRNA, APOC3 siRNA, and HBV siRNA, each targeting significant patient populations and addressing unmet clinical needs [7][29]. Financial Projections - Revenue is expected to grow significantly, with total revenue projected to reach 142.63 million RMB in 2024, reflecting a year-on-year increase of 324,052.27% [1]. - The company anticipates achieving profitability by 2030, with a 50% revenue sharing model with partners [7].

Investment Rating - The investment rating for the company is "Outperform the Market" (maintained) [1] Core Views - The company reported approximately 10% growth in offline retail for both its main brand and children's clothing in Q4 2025, with e-commerce showing high double-digit growth. The growth rates for the main brand and children's clothing remained stable quarter-on-quarter, while e-commerce growth showed a slight deceleration [2][3] - The company continues to innovate its product offerings to meet diverse consumer needs, with a total of 126 super stores established domestically, including 33 new openings in Q4. The first overseas store opened in Cambodia, marking a significant step in international market expansion [3][5][6] - The company maintains a stable inventory-to-sales ratio of 4.5-5.0 and retail discounts around 7.0-7.1, indicating effective inventory management amidst competitive pricing pressures [6][8] Summary by Sections Retail Performance - In Q4 2025, the adult apparel segment saw approximately 10% growth, while children's apparel also grew by about 10%. E-commerce experienced high double-digit growth, with the main brand and children's clothing growth rates remaining consistent [3][5] Product Innovation - The company has launched several new products across various categories, including running shoes, basketball shoes, outdoor gear, and fitness apparel, catering to a wide range of consumer preferences [5][6] Channel Expansion - The domestic super store count increased to 126, with 33 new stores opened in Q4. The company also entered the instant retail market by partnering with Taobao Flash Purchase, enhancing its online presence [6][8] Financial Forecast - The company expects to achieve net profits of 1.25 billion, 1.35 billion, and 1.48 billion yuan for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 8.5%, 8.7%, and 9.4% [8][9]

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company reported a retail revenue growth of approximately 10% year-on-year for its main brand and children's clothing in Q4 2025, with e-commerce platform sales also showing high double-digit growth [2][3] - The company maintains a brand strategy focused on technology and quality, launching new products across various categories, including running, basketball, and outdoor gear [4] - The company has established strategic partnerships to enhance brand visibility and technological integration, including collaborations with the Asian Olympic Council and other institutions [5][6] - The expansion of the company's retail network includes the opening of 126 super stores in mainland China and the first overseas store in Cambodia, indicating a commitment to both domestic and international growth [7] Financial Summary - The company forecasts revenues of 11.62 billion, 13.35 billion, and 15.32 billion yuan for 2025, 2026, and 2027 respectively, with net profits projected at 1.39 billion, 1.63 billion, and 1.87 billion yuan for the same years [9][11] - The earnings per share (EPS) are expected to be 0.67, 0.79, and 0.91 yuan for 2025, 2026, and 2027 respectively, with corresponding price-to-earnings (PE) ratios of 7.68, 6.57, and 5.72 [9][11]

Investment Rating - The report gives a "Buy" rating for Pop Mart (9992.HK) for the first time [1]. Core Views - Pop Mart is a leading cultural and entertainment company in China, focusing on IP incubation, consumer engagement, and the promotion of trendy toys [3]. - The company has established a comprehensive operational platform covering the entire trendy toy industry chain, leveraging its strong brand and designer partnerships [10]. Summary by Sections Company Overview - Pop Mart was founded in 2010 and has developed a robust platform around five key areas: global artist discovery, IP incubation, consumer engagement, trendy toy culture promotion, and related industry investment integration [3][10]. - The company has signed renowned designers and collaborated with global brands to create popular trendy toy products, building a strong fan base [10][14]. Horizontal Performance: IP Leadership in the Trendy Toy Market - The Chinese IP derivative and toy market is expected to grow significantly, with the market size projected to increase from RMB 99.4 billion in 2020 to RMB 174.2 billion by 2024, representing a compound annual growth rate (CAGR) of 15.1% [5][17]. - Pop Mart holds a market share of 11.5% in the trendy toy sector, positioning itself as a benchmark enterprise with strong global layout and IP operation capabilities [23]. Vertical Performance: Channel Growth Driving Revenue - The company has diversified its sales channels both domestically and internationally, utilizing offline retail stores, online platforms, and wholesale channels [35]. - In 2024, Pop Mart's revenue is expected to reach RMB 13.04 billion, a year-on-year increase of 106.9%, with a gross margin of 66.8% [35][58]. - The company has seen significant growth in its online sales, particularly through its blind box machines and e-commerce platforms like Douyin and Tmall [37][41]. Investment Recommendations - The report forecasts that Pop Mart's overall revenue will reach RMB 33.83 billion, RMB 47.92 billion, and RMB 61.83 billion in 2025, 2026, and 2027, respectively, with growth rates of 159.5%, 41.7%, and 29.0% [54][58]. - The net profit attributable to shareholders is projected to be RMB 7.95 billion, RMB 10.81 billion, and RMB 13.82 billion for the same years, reflecting year-on-year growth of 154.2%, 36.0%, and 27.9% [54][58].